Covered recipient · General Payments record
THOMAS TUYEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$1,799.64
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $690.05 | 33 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $355.76 | 14 |
| PFIZER INC. | $114.65 | 6 |
| Lilly USA, LLC | $65.76 | 4 |
| Novo Nordisk AS | $38.23 | 2 |
| Exact Sciences Corporation | $19.69 | 1 |
| DEXCOM, INC. | $18.76 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.40 | 1 |
| Merck Sharp & Dohme Corporation | $17.53 | 1 |
| Phathom Pharmaceuticals, Inc. | $13.99 | 1 |
| Abbott Laboratories | $13.87 | 1 |
| Acerta Pharma LLC | $13.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (33)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.87 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124803072 | CMS |
| ABBVIE INC. | $7.39 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255551 | CMS |
| ABBVIE INC. | $33.93 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255553 | CMS |
| ABBVIE INC. | $6.32 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255555 | CMS |
| ABBVIE INC. | $9.70 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255557 | CMS |
| ABBVIE INC. | $34.56 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255559 | CMS |
| ABBVIE INC. | $7.39 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255561 | CMS |
| ABBVIE INC. | $6.53 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255563 | CMS |
| ABBVIE INC. | $15.46 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255565 | CMS |
| ABBVIE INC. | $18.52 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255567 | CMS |
| ABBVIE INC. | $123.50 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255569 | CMS |
| ABBVIE INC. | $32.93 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255571 | CMS |
| ABBVIE INC. | $21.52 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255573 | CMS |
| ABBVIE INC. | $19.40 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255575 | CMS |
| ABBVIE INC. | $18.61 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106255577 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.41 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105700168 | CMS |
| Dexcom, Inc. | $18.76 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153340751 | CMS |
| Exact Sciences Corporation | $19.69 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114936892 | CMS |
| Lilly USA, LLC | $16.04 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135456779 | CMS |
| Lilly USA, LLC | $13.41 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135481987 | CMS |
| Lilly USA, LLC | $18.53 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135449342 | CMS |
| Lilly USA, LLC | $17.78 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135449344 | CMS |
| Merck Sharp & Dohme LLC | $17.53 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141960518 | CMS |
| Novo Nordisk Inc | $21.91 | 05/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097689753 | CMS |
| Novo Nordisk Inc | $16.32 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097835355 | CMS |
| PFIZER INC. | $14.12 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131165154 | CMS |
| PFIZER INC. | $16.48 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131484101 | CMS |
| PFIZER INC. | $19.32 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131647015 | CMS |
| PFIZER INC. | $23.54 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131781050 | CMS |
| PFIZER INC. | $16.69 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131950694 | CMS |
| PFIZER INC. | $24.50 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131179566 | CMS |
| Phathom Pharmaceuticals, Inc. | $13.99 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151134888 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.40 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153430467 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.